Non-steroidal anti-inflammatory drugs (NSAIDs), statins, glucocorticoids and monoclonal antibodies (e.g., targeting IL-6, TNF-, IL-12/23) have been reported to show moderate anti-depressant capacity in patients with somatic disorders (i.e., rheumatoid arthritis, psoriasis) who also had comorbid symptoms of depression [194, 195]
Get the ultimate glow with our unique Cola-flavored formula
A handy ampoule ensures maximum comfort of use: easy to consume at any time, no need to take many capsules or tablets, may be used at any time
Pfizer/Hospira and Fresenius Kabi set the documentation benchmark through FDA-registered cGMP manufacturing with per-lot COAs
If fatigue or other side effects become concerning, consulting a healthcare professional is key